Fig. 1. Flow diagram of the study. (i) Patients received ω3 (ii) patients received VitD (iii) patients received both ω3 and VitD and (iv) control as usual treatment group. 3.1. General characteristics of the participants at baseline Table 1 shows the participants’ baseline information ...